SDHAF2 and neuroblastoma: This makes it tempting to extrapolate a similar mechanism being present in neuroblastoma-derived SK-N-SH and SH-SY5Y cells that both accumulate SDHAF2 in response to antimycin A treatment (Fig. 7H) and have other metabolic characteristics of OXPHOS-adapted cells such as spare respiratory capacity (57).